Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santhosh Palani

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos Computational Biology|November 14, 2009
Integrating extrinsic and intrinsic cues into a minimal model of lineage commitment for hematopoietic progenitorsSanthosh Palani, Casim A Sarkar
Cell Reports|July 27, 2012
Transient noise amplification and gene expression synchronization in a bistable mammalian cell-fate switchSanthosh Palani, Casim A Sarkar
Molecular Systems Biology|April 1, 2011
Synthetic conversion of a graded receptor signal into a tunable, reversible switchSanthosh Palani, Casim A Sarkar
Biophysical Journal|May 13, 2008
Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switchSanthosh Palani, Casim A Sarkar
Journal of Lipid Research|January 5, 2007
Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolismYaguang Si, Santhosh Palani, Arul Jayaraman, et al.
The EMBO Journal|August 7, 2012
CSR-1 RNAi pathway positively regulates histone expression in C. elegansDaphne C Avgousti, Santhosh Palani, Yekaterina Sherman, et al.
Cell|January 11, 2011
Tunable signal processing in synthetic MAP kinase cascadesEllen C O'Shaughnessy, Santhosh Palani, James J Collins, et al.
The AAPS Journal|June 10, 2022
Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug ConjugatesKai H Liao, Jason H Williams, Santhosh Palani, et al.
Plos One|November 1, 2014
Dose schedule optimization and the pharmacokinetic driver of neutropeniaMayankbhai Patel, Santhosh Palani, Arijit Chakravarty, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinaseSanthosh Palani, Mayankbhai Patel, Jessica Huck, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos Computational Biology|November 14, 2009
Integrating extrinsic and intrinsic cues into a minimal model of lineage commitment for hematopoietic progenitorsSanthosh Palani, Casim A Sarkar
Cell Reports|July 27, 2012
Transient noise amplification and gene expression synchronization in a bistable mammalian cell-fate switchSanthosh Palani, Casim A Sarkar
Molecular Systems Biology|April 1, 2011
Synthetic conversion of a graded receptor signal into a tunable, reversible switchSanthosh Palani, Casim A Sarkar
Biophysical Journal|May 13, 2008
Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switchSanthosh Palani, Casim A Sarkar
Journal of Lipid Research|January 5, 2007
Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolismYaguang Si, Santhosh Palani, Arul Jayaraman, et al.
The EMBO Journal|August 7, 2012
CSR-1 RNAi pathway positively regulates histone expression in C. elegansDaphne C Avgousti, Santhosh Palani, Yekaterina Sherman, et al.
Cell|January 11, 2011
Tunable signal processing in synthetic MAP kinase cascadesEllen C O'Shaughnessy, Santhosh Palani, James J Collins, et al.
The AAPS Journal|June 10, 2022
Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug ConjugatesKai H Liao, Jason H Williams, Santhosh Palani, et al.
Plos One|November 1, 2014
Dose schedule optimization and the pharmacokinetic driver of neutropeniaMayankbhai Patel, Santhosh Palani, Arijit Chakravarty, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinaseSanthosh Palani, Mayankbhai Patel, Jessica Huck, et al.
Pageof 1